1. Home
  2. MURA vs KLXE Comparison

MURA vs KLXE Comparison

Compare MURA & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • KLXE
  • Stock Information
  • Founded
  • MURA 2013
  • KLXE 2018
  • Country
  • MURA Ireland
  • KLXE United States
  • Employees
  • MURA N/A
  • KLXE N/A
  • Industry
  • MURA
  • KLXE Oilfield Services/Equipment
  • Sector
  • MURA
  • KLXE Energy
  • Exchange
  • MURA Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • MURA 35.7M
  • KLXE 35.8M
  • IPO Year
  • MURA N/A
  • KLXE N/A
  • Fundamental
  • Price
  • MURA $2.07
  • KLXE $1.91
  • Analyst Decision
  • MURA Strong Buy
  • KLXE
  • Analyst Count
  • MURA 3
  • KLXE 0
  • Target Price
  • MURA $12.00
  • KLXE N/A
  • AVG Volume (30 Days)
  • MURA 479.2K
  • KLXE 93.0K
  • Earning Date
  • MURA 08-04-2025
  • KLXE 10-30-2025
  • Dividend Yield
  • MURA N/A
  • KLXE N/A
  • EPS Growth
  • MURA N/A
  • KLXE N/A
  • EPS
  • MURA N/A
  • KLXE N/A
  • Revenue
  • MURA N/A
  • KLXE $667,400,000.00
  • Revenue This Year
  • MURA N/A
  • KLXE N/A
  • Revenue Next Year
  • MURA N/A
  • KLXE $3.97
  • P/E Ratio
  • MURA N/A
  • KLXE N/A
  • Revenue Growth
  • MURA N/A
  • KLXE N/A
  • 52 Week Low
  • MURA $0.95
  • KLXE $1.46
  • 52 Week High
  • MURA $4.74
  • KLXE $7.40
  • Technical
  • Relative Strength Index (RSI)
  • MURA 51.50
  • KLXE 51.46
  • Support Level
  • MURA $2.05
  • KLXE $1.82
  • Resistance Level
  • MURA $2.09
  • KLXE $2.15
  • Average True Range (ATR)
  • MURA 0.01
  • KLXE 0.13
  • MACD
  • MURA 0.02
  • KLXE -0.00
  • Stochastic Oscillator
  • MURA 50.00
  • KLXE 40.00

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: